07: Doping for the Brain – Individual Freedom or Social Responsibility?
-
Hotel Alphof
Breakout
/
in deutscher SpracheSubstances originally developed for therapeutic indications are increasingly being used as neuroenhancers for improving the performance of healthy people and thus have high economic potential. Highly competitive (working) environments lead healthy people to use psychoactive substances in order to be able to compete at the top. How do we deal with (supposedly) autonomous enhancement decisions of individuals? What are the socio-cultural consequences? Should we take regulatory measures? Which role do the stakeholders of the healthcare system play?
|
Dr. Hedwig Josefine KAISER
Head, National and International Cooperation, University of Basel
| 1980 | Graduation MD Faculty of Medicine, University Vienna. |
| 1981-1985 | Postgraduate medical training, Landeskrankenanstalten, Salzburg |
| 1985 | Awarded as General Physician |
| 1985-1992 | Training in ophthalmology and optometry |
| 1992 | Awarded as Ophthlmologist |
| 1990-1991 | Scientific fellow, Eye Clinic, University Hospital Basel |
| 1992-1994 | Senior Physician, Eye Clinic, Landeskrankenanstalten, Salzburg |
| 1994-1995 | Scientific fellow, Eye Clinic, University Hospital Basel |
| 1997 | Habilitation, "Colour Doppler of the extraocular vessels", University of Basel |
| 1996-2003 | Chair, Department of Paediatric Ophthalmology, Strabismus and Neuroophthalmology, Eye Clinic, University Hospital Basel |
| 1998 | Appointed Professor, University of Basel |
| 2002-2009 | Dean of Education, Medical Faculty, University of Basel. |
| 2009-2017 | Vice-President, University of Basel |
| since 2014 | Head International Office, University of Basel |
